Neuboron Medtech Research Institute patents new agents for boron neutron capture therapy
Cancer Neuboron Medtech Research Institute Ltd. has disclosed boron-containing lipoic acid derivatives and vesicle forms acting as boron neutron capture therapy (BNCT) agents reported to be useful for the treatment of cancer. BioWorld Science Cancer …